Research map: Risk factors of advanced fibrosis in non-alcoholic fatty liver disease, associated with type 2 diabetes mellitus

Back to the article

Papers in this map

  1. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis · Zobair M. Younossi · 2019 · 2282 citations · Cited by this paper
  2. A clinical case of liver fibrosis in type 1 diabetes mellitus · 2026 · Related
  3. Changing epidemiology, global trends and implications for outcomes of NAFLD · Vincent Wai‐Sun Wong · 2023 · 750 citations · Cited by this paper
  4. The relationship of vitamin D-binding protein with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus · 2026 · Related
  5. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes · Veeral H. Ajmera · 2022 · 317 citations · Cited by this paper
  6. Oral Hypoglycemic Therapy in Metabolic Dysfunction-Associated Fatty Liver Disease · 2026 · Related
  7. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation · Christian Ludwig Roth · 2011 · 290 citations · Cited by this paper
  8. The evolution of concepts of inflammatory bowel diseases in children (literature review) · 2026 · Related
  9. The role of hepatokines in NAFLD · Norbert Stefan · 2023 · 285 citations · Cited by this paper
  10. Factors influencing the formation of the intestinal microbiota of a newborn (literature review) · 2026 · Related
  11. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary · Frank Tacke · 2024 · 206 citations · Cited by this paper
  12. Gastrointestinal manifestations and eating behavior in autism spectrum disorder: the role of sensory dysfunction and intestinal microbiota · 2026 · Related
  13. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes · Stefano Ciardullo · 2020 · 189 citations · Cited by this paper
  14. The work of the registry of precancerous diseases is a real way of primary prevention of stomach cancer · 2026 · Related
  15. Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association? · Ryan M. Kwok · 2013 · 179 citations · Cited by this paper
  16. Drug-induced liver injury associated with albendazole: a literature review and own clinical case of acute hepatitis C with liver failure in a 9-year-old child · 2026 · Related
  17. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease · Panu K. Luukkonen · 2021 · 167 citations · Cited by this paper
  18. Clinical and pathophysiological aspects of the development of chronic gastrointestinal diseases as predictors of overall aging · 2026 · Related
  19. High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold · Laurent Castéra · 2023 · 136 citations · Cited by this paper
  20. Chronic constipation in a comorbid patient - the place of lactulose in the therapy of a complex patient · 2026 · Related
  21. Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes: A Prospective Study · Xue Chen · 2022 · 86 citations · Cited by this paper
  22. Diabetes and cirrhosis: Current concepts on diagnosis and management · Laurent Castéra · 2023 · 82 citations · Cited by this paper
  23. Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines · Lijun Gong · 2023 · 55 citations · Cited by this paper
  24. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan · Tran Thi Khanh Tuong · 2020 · 48 citations · Cited by this paper
  25. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation · Tingwan Du · 2023 · 47 citations · Cited by this paper
  26. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus · Kaina Chen · 2020 · 46 citations · Cited by this paper
  27. Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases · Marion Mußbacher · 2021 · 45 citations · Cited by this paper
  28. RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease · Yunjia Li · 2022 · 44 citations · Cited by this paper
  29. Platelets and Platelet‐Derived Extracellular Vesicles in Liver Physiology and Disease · Alexandre Balaphas · 2019 · 43 citations · Cited by this paper
  30. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease · Shuai Yuan · 2022 · 42 citations · Cited by this paper
  31. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data · Behnam Saberi · 2018 · 41 citations · Cited by this paper
  32. Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis · Stefano Ciardullo · 2023 · 32 citations · Cited by this paper
  33. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study · Meryem Demir · 2018 · 29 citations · Cited by this paper
  34. Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis · Mitku Mammo Taderegew · 2023 · 29 citations · Cited by this paper
  35. Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies · Cosmina-Theodora Diaconu · 2022 · 25 citations · Cited by this paper
  36. Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes · Jisu Oh · 2023 · 23 citations · Cited by this paper
  37. Vitamin D alleviates liver fibrosis by inhibiting histidine-rich calcium binding protein (HRC) · Wanyi Lu · 2020 · 22 citations · Cited by this paper
  38. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B · Li‐Kun Zhong · 2020 · 20 citations · Cited by this paper
  39. Correlation between serum 25‑OH vitamin D expression and non‑alcoholic fatty liver disease · Jiayan Cai · 2020 · 19 citations · Cited by this paper

Source: OpenAlex (CC0)